CAMBRIDGE, Mass.--(BUSINESS WIRE)--Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that Abbie Celniker, Ph.D., CEO of Taligen Therapeutics was among the recipients of the Mass High Tech, Voice of New England Innovation, 2010 All-Star Awards. The All-Star Awards recognize 16 dynamic and influential leaders of New England’s innovation economy. This is the 15th year of the awards program.
